Court denies Boston Scientific a new trial for $324M stent suit

September 2008
Medical Device Daily;9/17/2008, Vol. 12 Issue 199, p3
The article reports on the decision of the U.S. District Court in Delaware to grant Johnson & Johnson's motion for entry of final judgment and denied Boston Scientific's motion for a new trial for a $324 million stent suit. Problems related to the stent patent infringement date back to 2005 when two separate jury verdicts found that Medtronic and Boston Scientific infringed the patents related to coronary stents held by Cordis, a business of Johnson & Johnson.


Related Articles

  • Gudiant suitor wins stent patent-infringement lawsuit.  // Indianapolis Business Journal;6/27/2005, Vol. 26 Issue 16, p31A 

    Reports that a Wilmington, Delaware jury ruled that Boston Scientific Corp.'s stents infringe on two patents owned by Johnson and Johnson. Johnson and Johnson is expected to close on the acquisition of Guidant Corp. in Indianapolis, Indiana in the third quarter; Ruling could cost Boston...

  • Boston Scientific guilty of patent infringement.  // Modern Healthcare;4/4/2005, Vol. 35 Issue 14, p34 

    Focuses on the decision released by a Delaware jury on a patent infringement case filed by Johnson & Johnson against Boston Scientific Corp. for offering a stent infringed on Johnson & Johnson's Palmaz patent. Impact of the decision on the ability of Boston to sell the Taxus drug-eluting stent.

  • Texas doc says Cypher, Taxus DES products infringe his patent.  // Cardiovascular Device Update;Dec2007, Vol. 13 Issue 12, p29 

    The article reports on the complaint filed by Wall Cardiovascular Technologies in Texas, alleging infringement of a coronary stent technology patent by Boston Scientific and Johnson & Johnson. According to the complaint, the patent was issued to Wall Cardiovascular founder W. Henry Wall for an...

  • Cordis a winner in latest battle of 'stent wars,' seeks damages.  // Medical Device Daily;1/9/2008, Vol. 12 Issue 6, p2 

    The article reports on the decision of the Court of Appeals for the Federal Circuit in Washington D.C. to upheld verdicts which found that Medtronic and Boston Scientific infringed the patents related to coronary stents held by Cordis. The court said they affirm the judgments against the...

  • Boston Sci to pay $716M to settle with J&J in stent war case.  // Medical Device Daily;10/1/2009, Vol. 13 Issue 189, p3 

    The article reports on a settlement between Boston Scientific and Johnson & Johnson wherein Boston will pay 716 million U.S. dollars to settle litigation with Johnson & Johnson over intellectual property rights tied to Boston Scientific's cardiac stents. The payment will be made by Boston...

  • PATENT NEWS.  // Medical Technology & Devices Week;12/3/2007, Vol. 5 Issue 47, p1 

    The article reports on the infringement complaint filed by Marshall, Texas-based Wall Cardiovascular Technologies against Massachusetts-based Boston Scientific and New Jersey-based Johnson & Johnson. Wall alleges that some of Boston Scientific's products are based on its coronary stent...

  • Texas physician charges Taxus, Cypher DES infringe his patent.  // Medical Device Daily;11/28/2007, Vol. 11 Issue 215, p2 

    The article reports on a patent infringement suit filed by Wall Cardiovascular Technologies against Boston Scientific and Johnson & Johnson. The company claims that the Boston and Johnson & Johnson infringed its coronary stent technology patent. It further claims that some of the products of...

  • Boston Scientific ordered to pay $250 million in patent suit.  // Biomedical Business & Technology;Jun2008, Vol. 31 Issue 6, p29 

    The article reports that Boston Scientific has been ordered by a U.S. District Court jury in Marshall, Texas, in late May 2008 to pay Medtronic $250 million in damages for infringing on three of its patents. According to Medtronic spokesman Daniel Beach, they believe the jury did a good job of...

  • Boston Sci promises appeal of $431 million infringement ruling.  // Cardiovascular Devices & Drugs;Feb2008, Vol. 14 Issue 2, p22 

    The article reports that a jury has ordered medical device maker Boston Scientific, to pay $431 million in damages to Doctor Bruce Saffran, a radiologist from New Jersey who charged that Boston Scientific's drug-eluting stents infringe patents that he received in 1997. Boston Scientific called...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics